Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for the treatment of knee osteoarthritis in overweight or obese adults
ChiCTR2500107918Phase 4Not yet recruiting
- Sponsor
- Xi'an Honghui Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in knee osteoarthritis (OA) comparing Metformin group with Placebo group (2 arms). Primary endpoint: Visual analogue scale (VAS) for knee pain. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2500107918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107918.